Oct
2026
Fiera Milano, Italy
Visit us
stand 10F17, Contract Manufacturing & Services

WuXi STA

Exhibitor at CPHI Milan 2026
About Us

WuXi STA, an integrated part of WuXi AppTec, is an industry-leading pharmaceutical development and manufacturing technology platform serving the life sciences industry with operations across North America, Europe and Asia. As an innovative Contract Research, Development, and Manufacturing Organization (CRDMO) supporting small molecule new drug development, WuXi STA offers our worldwide partners efficient, flexible, and high-quality solutions from preclinical to commercialization.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    United States
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    5000+
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
Primary activities
API Producer
Biopharmaceutical
Chemical Development
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 10F17, Contract Manufacturing & Services

Products Featured at CPHI Milan 2026

  • Bioavailability Enhancement & Advanced Delivery Technologies

    Product Bioavailability Enhancement & Advanced Delivery Technologies

    Our bioavailability toolbox offers a customizable solution to your drug delivery challenges. 

    - Spray-Dried Dispersion (SDD)
    - Hot Melt Extrusion (HME)
    - Nano-suspensions & Lipid Nanoparticles 
    - Softgel & Liquid Filled Capsules
    - Injectable Formulations\


  • Peptide CRDMO Platform

    Product Peptide CRDMO Platform

    WuXi TIDES's Peptide platform includes a complete offering of services to bring your protein therapeutic to market faster while supporting a wide variety of conjugates including PPMO, Peptide-Antibody, Peptide-Linkers.

    Services include but are not limited to: - Comprehensive Discovery Service...
  • Oligonucleotide CRDMO Platform

    Product Oligonucleotide CRDMO Platform

    WuXi TIDES has a robust and integrated Oligo API Platform, offering R&D and manufacturing services from preclinical to commercial scale and operating out of our US FDA inspected facility based in Changzhou, China. We support the development and manufacture of a variety of oligonucleotide modalities inc...
  • Highly Potent API (HPAPI), ADC Payload, and Payload-Linker Manufacturing

    Product Highly Potent API (HPAPI), ADC Payload, and Payload-Linker Manufacturing

    Our Jinshan and Changzhou sites are equipped with multiple R&D labs as well as a dedicated cGMP HP Kilo lab and plant for producing and manufacturing highly potent APIs (HPAPI's), antibody drug conjugates (ADC's), payloads, and payload-linkers. We currently offer drug product manufacturing at STA’...
  • Analytical Development Services

    Product Analytical Development Services

    Our comprehensive suite of analytical services help to supplement the development and manufacture of your product, ensuring high quality and consistency throughout the process.

    Services include: 
    - Analytical method development and validation  
    - API and drug product release tes...

WuXi STA Resources (1)